Detalhe da pesquisa
1.
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
Proc Natl Acad Sci U S A
; 120(41): e2220403120, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796985
2.
Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
J Immunol
; 210(9): 1257-1271, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881867
3.
A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
Proc Natl Acad Sci U S A
; 119(33): e2201616119, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895717
4.
Opposing effects of acellular and whole cell pertussis vaccines on Bordetella pertussis biofilm formation, Siglec-F+ neutrophil recruitment and bacterial clearance in mouse nasal tissues.
bioRxiv
; 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328073
5.
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization.
Front Immunol
; 14: 1181876, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275891